Event

Journal Club - Sample Size Re-Estimation Techniques

Add to:

Daniel Wachtlin and Andrew Jones presented at our joint event with the DIA.

Joint PSI Pharmaceutical Statistics & DIA Statistics Community

DIA Chair: Tad Archambault, Principal, Virtu Stat, Ltd.

Speaker: Daniel Wachtlin, Interdisciplinary Centre for Clinical Trials (IZKS), University Medical Centre Mainz
Blinded Sample Size Recalculation in Longitudinal Clinical Trials Using Generalized Estimating Equations
Daniel Wachtlin and Meinhard Kieser
Therapeutic Innovation & Regulatory Science, Vol. 47, Issue 4, pp. 460-467, 2013
Abstract | Paper+Slides
 
 
PSI Chair: Byron Jones, NOVARTIS

Speaker: Andrew Hartley, PPD
Adaptive blinded sample size adjustment for comparing two normal means—a mostly Bayesian approach
Andrew M. Hartley
Pharmaceutical Statistics, Vol. 11, Issue 3, pp. 230-240, 2012
Abstract | Paper+Slides
 
 
Discussant: Peiling Yang, Statistical Team Leader, Division of Biometrics I, US FDA
Slides

+ Papers available to view from October 22nd 2013 to November 5th 2013.

For a flier advertising the event, please click here.

To access the recording, please visit the Video-on-Demand Library.
 

Upcoming Events

Latest Jobs